JeannyB.Aragon-ChingMDFACP

Genitourinary Oncology

Clinical Program Director of Genitourinary Cancers; Medical Director of Clinical Research; Inova Schar Cancer Institute; Associate Professor of Medical Education, University of Virginia

Join to view full profile

Dr. Aragon-Ching is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Aragon-Ching's full profile

Already have an account?

Office
8081 Innovation Park Dr
Level 5 - Great Falls Clinic
Fairfax, VA 22031
Phone+1 571-472-1180

Fax+1 571-472-1197

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2004 - 2008
Albert Einstein Healthcare NetworkChief Residency, Internal Medicine, 2003 - 2004
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2000 - 2003
University of Santo TomasClass of 1997
University of Santo TomasBS, Physical Therapy, Cum Laude, 1988 - 1993

Certifications & Licensure

VA State Medical License 2015 - 2026
DC State Medical License 2008 - 2018
MD State Medical License 2004 - 2018
PA State Medical License 2001 - 2004
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Best Prostate Cancer Oncologists 2024 Newsweek, 2024
Named Top Doctor Northern Virginia Magazine, 2017, 2019-2021
Named Top Doctor Washingtonian, 2018
Named Top Doctor International Association of Oncologists, 2018
ASCO Leadership Development Program American Society of Clinical Oncology, 2017-2018
Named Best Doctors Virginia Living Magazine, 2017
Named in 2014/2015 Top Doctors Washingtonian Magazine
Fellowship American College of Physicians
Co-recipient Elaine Snyder Cancer Research Award
Join now to see all

Clinical Trials

S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
Active, not recruiting
Phase 3
A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors Start of enrollment: 2015 Jan 01
Completed
Phase 1, Phase 2
A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer Start of enrollment: 2015 Jul 13
Completed
Phase 3
A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer Start of enrollment: 2017 Jan 16
Completed
Phase 4
A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney Start of enrollment: 2017 Jul 07
Completed
Phase 3
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer Start of enrollment: 2017 Nov 03
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.
Neal D Shore, Christian Gratzke, Susan Feyerabend, Patrick Werbrouck, Joan Carles
The Oncologist. 2024-07-05
Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients.
David J Einstein, Jeanny B Aragon-Ching, Fatima Karzai, Ravi A Madan
Current Opinion in Oncology. 2024-05-01
Refining the subgroup analyses and optimal patient population in the JAVELIN Bladder 100 trial.
Jeanny B Aragon-Ching
Translational Andrology and Urology. 2024-04-30

Journal Articles

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
Cora N Sternberg, Jeanny B Aragon-Ching, Daniel P Petrylak, Petros Grivas, The New England Journal of Medicine
The Emerging Role of Combination Angiogenesis Inhibitors and Immune Checkpoint Inhibitors in the Treatment of Metastatic Renal Cell Cancer
Nizam A, Logan R, Gupta B, Aragon-Ching, JB, Kidney Cancer, 8/7/2019

Lectures

Metastatic RCC trials: Balancing efficacy and quality-of-life
EAU Annual Congress 2021 - 7/9/2021
Current Approaches to Urothelial and Variant Cancers: Tumor Board Presentation
ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
ABCs of ADT
Hotel Monaco, Washington, DC; National Alliance of State Prostate Cancer Coalition - 10/19/2019
Current Approaches to Urothelial and Variant Cancers: Tumor Board Presentation
ASCO Annual Meeting 2019 - 6/2/2019
Debate: The Optimal Local Treatment for Muscle-Invasive Bladder Cancer
ASCO GU Cancers Symposium; San Francisco, CA - 2/2019
Challenges of Perioperative Systemic Therapy of Localized Urothelial Cancer
2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
AUA Crossfire Debate Plenary Session:Oligometastatic Castrate Sensitive Prostate Cancer is best treated by Focal Ablation
San Francisco, CA
Chemotherapy Options for Advanced Prostate Cancer
NASPCC 14th Annual Meeting, Washington, DC - 10/2018
Join now to see all

Other

Key Abstracts GU Cancers ASCO 2024
Neeraj Agrawal and JeannyAragon-Ching
https://dailynews.ascopubs.org/do/podcast-key-abstracts-gu-cancers-asco24
5/25/2024
First-Line Treatment of Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: The Pursuit of Improved Outcomes
Aragon-Ching JB, Grivas P., ASCO Daily News
https://dailynews.ascopubs.org/do/first-line-treatment-cisplatin-ineligible-patients-metastatic-urothelial-carcinoma
1/17/2023
Advances in Genitourinary Cancers at ASCO22
Neeraj Agrawal and Jeanny Aragon-Ching, ASCO Daily News
https://dailynews.ascopubs.org/do/10.1200/ADN.22.0618/full/
6/18/2022
Podcast: Key Posters on Advances in GU Cancers at ASCO22
Neeraj Agrawal and Jeanny Aragon-Ching, ASCO Daily News
https://dailynews.ascopubs.org/do/10.1200/ADN.22.05.26.2/full/
5/26/2022
Novel Therapies Advance the Field of GU cancers
Geraldine Carroll, ASCO Daily News
https://dailynews.ascopubs.org/do/10.1200/ADN.21.200487/full/
3/3/2021
Dr. Jeanny Aragon-Ching Highlights Key Research in Genitourinary Cancers
Jeanny Aragon-Ching, ASCO Daily News Podcast
http://ascodaily.ascou.libsynpro.com/dr-jeanny-aragon-ching-highlights-key-research-in-genitourinary-cancers
ASCO Daily News - 1/9/2020
Need-to-Know Data for a Treatment Option in Advanced RCC
John Russell, MD and Jeanny Aragon-Ching, MD, ReachMD
https://reachmd.com/programs/medical-industry-feature/need-to-know-data-for-a-treatment-option-in-advanced-rcc/10999/
ReachMD Online - 12/19/2019
Moving Towards Treating Nonmetastatic CRPC: Analyzing the Emerging Role of Antiandrogen Therapies – Expert Panel Discussion
George K. Philips, MBBS, MD, MPH, Jeanny Aragon-Ching, MD, and Ross E. Krasnow, MD, MPH, Medstar Health
http://prostatecancercme.com/courses/moving-towards-treating-nonmetastatic-crpc-analyzing-the-emerging-role-of-antiandrogen-therapies-expert-panel-discussion
Washington, DC - 10/10/2018
Join now to see all

Authored Content

How We Treat Metastatic Renal Cell Carcinoma: Options Beyond First-Line TherapyJanuary 2023
Controversies Surrounding the Use of Novel Antiandrogens in Nonmetastatic Castrate-Resistant Prostate CancerNovember 2019
Perspective on Targeted radiation therapy yields high response rates in metastatic prostate cancerFebruary 2019
The Evolving Treatment Landscape for Nonmetastatic Castration-Resistant Prostate CancerJanuary 2019
Contemporary systemic therapy for advanced urothelial carcinoma11/1/2018
Prostate, Bladder & Non-urothelial cancers, RCC and Germ Tumor Questions9/21/2017
Join now to see all

Press Mentions

America's Best Prostate Cancer Oncologists 2024June 20th, 2024
Nivolumab Plus Chemotherapy Shows Durable Disease Control, Improved Survival in Lymph Node–Only Metastatic Urothelial CarcinomaJune 3rd, 2024
Metformin Does Not Slow Disease Progression in Low-Risk Prostate CancerJune 1st, 2024
Join now to see all

Committees

Track Chair Urothelial Carcinoma, ASCO GU Cancers Symposium Committee 2019 2018 - Present
Member, Bladder; Track co-chair, Renal, ASCO GU Cancers Symposium Committee 2017 - 2018
Member, ASCO Cancer Education Committe 2016 - 2018
Member, Prostate; Track Chair - Renal, ASCO GU Cancers Committee 2016 - 2017